Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

axapharm ag - acido valproicum - capsule - acido valproicum 500 mg, excipiens pro capsula. - antiepilepticum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

bayer (schweiz) ag - simeticonum - gocce - simeticonum 41.2 mg, natrii cyclamas, saccharinum natricum, arom.: vanillinum e altri, conserv.: e 200, e 202, excipiens ad una soluzione per 1 ml, corrisp. dosi 2. - gonfiore - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

axapharm ag - natrii valproas - sirup - natrii valproas 50 mg, sono, saccharinum natricum, natrii cyclamas, conserv.: propylis parahydroxybenzoas, e 218, excipiens ad una soluzione per 1 ml. - antiepilepticum - synthetika

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

viatris healthcare limited - clozapina - clozapina

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

organon gmbh - mometasoni-17 furoas - erogazione spray nasale - mometasoni-17 furoas 0.5 mg, cellulosum microcristallinum et carmellosum natricum, glycerolum, acidum citricum monohydricum, natrii citras dihydricus, polysorbatum 80, benzalkonii chloridum 0.2 mg, aqua purificata, ad suspensionem pro 1 g corresp., mometasoni-17 furoas 50 µg pro dosi, doses pro vase 140. - rinite, nasenpolypen - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

grünenthal pharma ag - esomeprazolum - mup-tabletten - esomeprazolum 20 mg a esomeprazolum magnesicum trihydricum, glyceroli monostearas 40-55, hydroxypropylcellulosum, hypromellosum, magnesio stearas, acidi methacrylici e ethylis acrylatis polymerisatum 1:1, cellulosum microcristallinum, paraffinum solido syntheticum, macrogolum 6000, polysorbatum 80, crospovidonum, natrii stearylis fumaras, zucchero sfere, talco, triethylis citras, e 171, e 172 (giallo) e 172 (rosso), per compresso corrisp. sodio 0.034 mg. - protonenpumpenblocker - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

grünenthal pharma ag - esomeprazolum - mup-tabletten - esomeprazolum 40 mg a esomeprazolum magnesicum trihydricum, glyceroli monostearas 40-55, hydroxypropylcellulosum, hypromellosum, magnesio stearas, acidi methacrylici e ethylis acrylatis polymerisatum 1:1, cellulosum microcristallinum, paraffinum solido syntheticum, macrogolum 6000, polysorbatum 80, crospovidonum, natrii stearylis fumaras, zucchero sfere, talco, triethylis citras, e 171, e 172 (rosso), per compresso haze corrisp. sodio 0.048 mg. - protonenpumpenblocker - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

a. menarini gmbh - ranolazinum - retardtabletten - ranolazinum 375 mg, cellulosum microcristallinum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, hypromellosum, magnesii stearas, natrii hydroxidum corresp. natrium 1.15 mg, Überzug: hypromellosum, macrogolum 400, polysorbatum 80, cera carnauba, e 171, e 132, pro compresso obducto. - angina pectoris - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

a. menarini gmbh - ranolazinum - retardtabletten - ranolazinum 500 mg, cellulosum microcristallinum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, hypromellosum, magnesii stearas, natrii hydroxidum corresp. natrium 1.54 mg, Überzug: macrogolum 3350, poly(alcohol vinylicus), talcum, cera carnauba, e 171, e 172 (flavum), e 172 (rubrum), pro compresso obducto. - angina pectoris - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

a. menarini gmbh - ranolazinum - retardtabletten - ranolazinum 750 mg, cellulosum microcristallinum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, hypromellosum, magnesii stearas, natrii hydroxidum corresp. natrium 2.29 mg, Überzug: triacetinum, hypromellosum, lactosum monohydricum 12 mg, cera carnauba, e 171, e 102 40 µg, e 133, pro compresso obducto. - angina pectoris - synthetika